Literature DB >> 3203602

Fibronectin quantification in plasma and vitreous by a noncompetitive ELISA technique.

M Weller1, P Wiedemann, K Heimann, K Zilles.   

Abstract

Fibronectin, a high-molecular glycoprotein of the extracellular matrix and plasma, has provoked increasing interest in ophthalmology because of its possibly important role in the pathogenesis of proliferative vitreoretinopathy (PVR). A quantitative determination of fibronectin in vitreous aspirates is necessary for the evaluation of this glycoprotein in PVR. A noncompetitive enzyme-linked immunosorbent assay (ELISA) was developed for the quantification of immunoreactive fibronectin in human plasma samples and vitreous aspirates. Here, procedures to establish an ELISA for the clinical laboratory routine are discussed and possible pitfalls during the assay standardization are described.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3203602     DOI: 10.1007/bf00162748

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  9 in total

Review 1.  Recent advances in research on fibronectin and other cell attachment proteins.

Authors:  K M Yamada; S K Akiyama; T Hasegawa; E Hasegawa; M J Humphries; D W Kennedy; K Nagata; H Urushihara; K Olden; W T Chen
Journal:  J Cell Biochem       Date:  1985       Impact factor: 4.429

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 3.  Immunoblotting and dot immunobinding--current status and outlook.

Authors:  H Towbin; J Gordon
Journal:  J Immunol Methods       Date:  1984-09-04       Impact factor: 2.303

4.  Vitreous aspirates from patients with proliferative vitreoretinopathy stimulate retinal pigment epithelial cell migration.

Authors:  P A Campochiaro; J A Jerdan; B M Glaser; A Cardin; R G Michels
Journal:  Arch Ophthalmol       Date:  1985-09

5.  The use of avidin-biotin interaction in immunoenzymatic techniques.

Authors:  J L Guesdon; T Ternynck; S Avrameas
Journal:  J Histochem Cytochem       Date:  1979-08       Impact factor: 2.479

6.  [Proliferative vitreoretinopathy. Pathogenesis and possibilities for treatment with cytostatic drugs].

Authors:  P Wiedemann; K Heimann
Journal:  Klin Monbl Augenheilkd       Date:  1986-06       Impact factor: 0.700

7.  Enzyme-linked immunosorbent assay to quantify fibronectin.

Authors:  M J Gomez-Lechon; J V Castell
Journal:  Anal Biochem       Date:  1985-02-15       Impact factor: 3.365

8.  [The use of laser nephelometry for the determination and computer-assisted calculation of the fibronectin concentration in various body fluids (author's transl)].

Authors:  A M Gressner; P Wallraff
Journal:  J Clin Chem Clin Biochem       Date:  1980-11

9.  Immunochemical characterization of human plasma fibronectin.

Authors:  M Vuento; E Salonen; K Salminen; M Pasanen; U K Stenman
Journal:  Biochem J       Date:  1980-12-01       Impact factor: 3.857

  9 in total
  2 in total

1.  The significance of vitronectin in proliferative diabetic retinopathy.

Authors:  P Esser; M Bresgen; M Weller; K Heimann; P Wiedemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-08       Impact factor: 3.117

2.  Ff-nano, short functionalized nanorods derived from Ff (f1, fd, or M13) filamentous bacteriophage.

Authors:  Sadia Sattar; Nicholas J Bennett; Wesley X Wen; Jenness M Guthrie; Len F Blackwell; James F Conway; Jasna Rakonjac
Journal:  Front Microbiol       Date:  2015-04-20       Impact factor: 5.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.